Evaluation design of a systematic, selective, internet-based, Chlamydia screening implementation in the Netherlands, 2008-2010: Implications of first results for the analysis

BMC Infectious Diseases

Volumn 10, Issue , 2010, Pages

  van den Broek, Ingrid V F ^a   Hoebe, Christian J P A ^b   van Bergen, Jan E A M ^c   Brouwers, Elfi E H G ^b   de Feijter, Eva M ^c   Fennema, Johannes S A ^d   Götz, Hannelore M ^e   Koekenbier, Rik H ^d   van Ravesteijn, Sander M ^e   Op de Coul, Eline L M ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b South Limburg Public Health Service   (Netherlands)

^c National Institute for STI and AIDS Control in the Netherlands   (Netherlands)

^d Online Research and Prevention Unit Amsterdam Health Service ^*  (Netherlands)

^e Rotterdam Rijnmond Public Health Service   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; FEMALE; HUMAN; INTERNET; MALE; NETHERLANDS; NONHUMAN; PREDICTION; PREVALENCE; QUESTIONNAIRE; RURAL AREA; SCREENING; SIMULATION; CHLAMYDIASIS; HEALTH CARE QUALITY; ISOLATION AND PURIFICATION; MASS SCREENING; METHODOLOGY; PATIENT PARTICIPATION; RURAL POPULATION; URBAN POPULATION;

CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FEMALE; HUMANS; INTERNET; MALE; MASS SCREENING; NETHERLANDS; PATIENT PARTICIPATION; PREVALENCE; PROGRAM EVALUATION; RURAL POPULATION; URBAN POPULATION;

EID: 77950682976     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-10-89     Document Type: Article

References (24)

1. Rekart M, Brunham RC. Epidemiology of chlamydial infection: are we losing ground?. Sex Transm Infect 2008, 84(2):87-91. 10.1136/sti.2007.027938, 18216155.
2. Nelson H, Helfand M. Screening for chlamydial infection. Am J Prev Med 2001, 20(3 Suppl):95-107. 10.1016/S0749-3797(01)00253-7, 11306238.
3. Low N, Bender N, Nartey L, Shang A, Stephenson JM. Effectiveness of Chlamydia screening: systematic review. Int J Epidemiol 2009, 38:435-448. 10.1093/ije/dyn222, 19060033.
4. Scholes D, Stergachis A, Heidrich FE, Andrilla H, Holmes KK, Stamm WE. Prevention of pelvic inflammatory disease by screening for cervical Chlamydia infection. New Engl J Med 1996, 334:1362-1366. 10.1056/NEJM199605233342103, 8614421.
5. Østergaard L, Andersen B, Møller JK, Olesen F. Home sampling versus conventional swab sampling for screening of Chlamydia trachomatis in women; a cluster-randomized 1-year follow-up study. Clin Infect Dis 2000, 31:951-957. 10.1086/318139, 11049776.
6. Low N, McCarthy A, Macleod J, , et al. for the Chlamydia Screening Studies Project Group Epidemiological, social, diagnostic and economic evaluation of population screening for genital chlamydial infection. Health Technology Assessment 2007, 11(8). for the Chlamydia Screening Studies Project Group.
7. van Bergen J, Götz HM, Richardus JH, Hoebe CJ, Broer J, Coenen AJ. Prevalence of urogenital Chlamydia trachomatis increases significantly with level of urbanisation and suggests targeted screening approaches: results from the first national population based study in the Netherlands. Sex Transm Infect 2005, 81(1):17-23. 1763744, 15681716, 10.1136/sti.2004.010173.
8. Gezondheidsraad Screenen op Chlamydia [Screening for Chlamydia]. Gezondheidsraad rapport [Health Council Report] 2004, 07. Gezondheidsraad.
9. Gezondheidsraad Jaarbericht Gezondheidsonderzoek. Den Haag Gezondheidsraad Publicatie [The Hague Health Council Publication] 2006, 10. Gezondheidsraad.
10. van Bergen JEAM, Fennema JSA, Broek IVF, Brouwers EEHG, de Feijter EM, Hoebe CJPA, Koekenbier RH, Op de Coul ELM, van Ravesteijn SM, Götz HM. Rationale, design and results of the first screening round of a comprehensive, register-based Chlamydia Screening Implementation programme in the Netherlands. 2010,
11. Op de Coul ELM, Weenen TC, Sande MAB, Broek IVF, et al. Process evaluation of the Chlamydia Screening Implementation in the Netherlands: phase 1. RIVM Report 210261006, Bilthoven 2009, , http://www.rivm.nl/bibliotheek/rapporten/210261006.html
12. Götz HM, van Bergen JE, Veldhuijzen IK, Broer J, Hoebe CJ, Steyerberg EW, Coenen AJ, de Groot F, Verhooren MJ, van Schaik DT, et al. A prediction rule for selective screening of Chlamydia trachomatis infection. Sex Transm Infect 2005, 81(1):24-30. 1763735, 15681717, 10.1136/sti.2004.010181.
13. Brown C, Lilford RJ. The stepped wedge trial design: a systematic review. BMC Medical Research Methodology 2006, 6:54. 1636652, 17092344, 10.1186/1471-2288-6-54.
14. Koedijk F, Vriend HJ, van Veen MG, Op de Coul ELM, Broek IVF, van Sighem AI, Verheij RA, Sande MAB. Sexually transmitted infections, including HIV, in the Netherlands in 2008. RIVM Annual Report 2009,
15. Kretzschmar M, Welte R, Hoek JA, et al. Comparative model-based analysis of screening programs for Chlamydia trachomatis infections. Am J Epidemiol 2001, 153:90-101. 10.1093/aje/153.1.90, 11159151.
16. Kretzschmar M, Turner KME, Barton PM, Edmunds J, Low N. Predicting the population impact of chlamydia screening programmes: comparative mathematical modelling study. Sex Transm Inf 2009,
17. Welte R, Kretzschmar M, Leidl R, Hoek JAR, Jager JC, Postma MJ. Cost-effectiveness of screening programs for Chlamydia trachomatis: a population-based dynamic approach. Sex Transm Dis 2000, 27:518-529. 10.1097/00007435-200010000-00005, 11034526.
18. Welte R, Postma M, Leidl R, Kretzschmar M. Costs and effects of chlamydial screening: dynamic versus static modeling. Sex Transm Dis 2005, 32:474-483. 10.1097/01.olq.0000161181.48687.cf, 16041248.
19. Andersen B, Gundgaard J, Kretzschmar M, Olsen J, Welte R, Østergaard L. Prediction of costs, effectiveness, and disease control of a population based program using home sampling for diagnosis of urogenital Chlamydia trachomatis Infections. Sexually Transmitted Diseases 2006, 33(7):407-415. 10.1097/01.olq.0000200609.77577.3f, 16601656.
20. van Valkengoed I, Boeke AJ, Brule AJ, Morré SA, Dekker JH, Meijer CJ, van Eijk JT. [Systematic home screening for Chlamydia trachomatis infections of asymptomatic men and women in family practice by means of mail-in urine samples]. Ned TijdschrGeneeskd 1999, 27(13):672-676.
21. Macleod J, Salisbury C, Low N, McCarthy A, Sterne JA, Holloway A, Patel R, Sanford E, Morcom A, Horner P, Davey Smith G, Skidmore S, Herring A, Caul O, Hobbs FD, Egger M. Coverage and uptake of systematic postal screening for genital Chlamydia trachomatis and prevalence of infection in the United Kingdom general population: cross sectional study. BMJ 2005, 330(7497):940. 556339, 15809231, 10.1136/bmj.38413.663137.8F.
22. LaMontagne S, Baster K, Emmet L, et al. Incidence and reinfection rates of genital chlamydia infection among women aged 16-24 years attending general practice, family planning and genitourinary medicine clinics in England: a prospective cohort study by the Chlamydia Recall Study Advisory Group. Sex Transm Infect 2007, 83:292-303. 10.1136/sti.2006.022053, 17050567.
23. Novak D, Karlsson RB. Simplifying chlamydia testing: an innovative Chlamydia trachomatis testing approach using the internet and a home sampling strategy: population based study. Sex Transm Inf 2006, 82:142-147.
24. Götz HM, Veldhuijzen IK, van Bergen JE, Hoebe CJ, de Zwart O, Richardus JH, van Bergen JE, Broer J, Coenen AJ, Gotz HM, et al. Acceptability and consequences of screening for chlamydia trachomatis by home-based urine testing. Sex Transm Dis 2005, 32(9):557-562. 10.1097/01.olq.0000175416.15905.db, 16118604.